Spero Therapeutics
Nivedita Bhatt's most recent work experience is as a Senior Director at Spero Therapeutics since January 2022. Prior to this role, they worked as a Biostatics Consultant in the field of consulting starting in March 2021. Their previous experience includes working as an Associate Director at Horizon from December 2015 to November 2020.
Nivedita Bhatt holds a Doctor of Philosophy (PhD) degree in Statistics from the Fox School of Business at Temple University. The specific years of their education are not provided.
This person is not in any offices
Spero Therapeutics
2 followers
Spero Therapeutics (Nasdaq: SPRO) is a multi-asset pre-commercial stage biopharmaceutical company in Cambridge, Mass. We are highly committed to advancing novel treatment approaches for bacterial infections with a world-class team of biotechnological and biopharmaceutical experts. The company has a pipeline of novel and highly differentiated antibacterial and rare disease product candidates focused on patients' unmet needs with multi-drug resistant (MDR) bacterial infections.